Hospital
Upland Hills Health, INC.
Upland Hills Health, INC. was paid $6.50M by Medicaid between Jan 2018 and Dec 2024, across 113 billing codes. Its largest line is 96361, Intravenous infusion, hydration; each additional hour — 17% of everything it billed.
33Billing provider infoUPLAND HILLS HEALTH, INC.
DODGEVILLE, WI 53533
DODGEVILLE, WI 53533
33aNPI1487745501assigned 09/27/2006
33bProvider typeCritical Access Hospital
28Total paid$6.50M
24GClaims130,694
24DCodes billed113
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Wisconsin
Rank by total paid#22 of 48
Median peer was paid$4.30M
This provider vs. median1.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official SCHNEDLER, LISA controls 12+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,217 | $765K | |
| 2019 | 16,066 | $724K | |
| 2020 | 12,927 | $602K | |
| 2021 | 19,363 | $891K | |
| 2022 | 22,093 | $1.19M | |
| 2023 | 24,409 | $1.28M | |
| 2024incomplete | 19,619 | $1.04M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 96361 | Intravenous infusion, hydration; each additional hour | 17% | 3,122 | 2,319 | $1.11M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 5,419 | 4,240 | $864K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 11% | 4,175 | 3,495 | $689K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 10% | 5,001 | 4,332 | $672K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 7.0% | 2,875 | 2,246 | $453K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.3% | 2,072 | 1,791 | $347K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 5.0% | 2,110 | 1,884 | $325K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4.9% | 1,538 | 981 | $316K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.1% | 3,203 | 2,184 | $264K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.3% | 1,974 | 1,688 | $212K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3.1% | 984 | 865 | $203K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.2% | 646 | 574 | $145K |
101 more codes
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.5% | 2,931 | $98K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.5% | 2,508 | $96K |
| 87631 | 1.3% | 750 | $87K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 259 | $57K |
| 80053 | Comprehensive metabolic panel | <1% | 6,146 | $47K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 443 | $39K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,516 | $36K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,647 | $35K |
| 59025 | Fetal non-stress test | <1% | 127 | $31K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 279 | $28K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 216 | $24K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 216 | $21K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 777 | $21K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 176 | $19K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 40 | $17K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,841 | $16K |
| 73630 | <1% | 618 | $16K | |
| 81025 | <1% | 1,776 | $12K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 75 | $12K |
| 84484 | <1% | 2,299 | $11K | |
| 83605 | <1% | 1,850 | $10K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 678 | $9K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 978 | $9K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 455 | $9K |
| G0378 | Hospital observation service, per hour | <1% | 184 | $9K |
| 83690 | <1% | 1,859 | $8K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 272 | $8K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 53 | $8K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,731 | $8K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 27 | $8K |
| 81001 | <1% | 2,707 | $6K | |
| 87070 | <1% | 703 | $6K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 27 | $6K |
| 85027 | <1% | 1,146 | $5K | |
| 76830 | Ultrasound, transvaginal | <1% | 43 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 797 | $4K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 3,203 | $4K |
| 82962 | <1% | 1,802 | $4K | |
| 73610 | <1% | 187 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 377 | $4K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,597 | $3K |
| 83880 | <1% | 255 | $3K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 66 | $3K |
| 81003 | <1% | 1,232 | $2K | |
| 82077 | <1% | 288 | $2K | |
| 83735 | <1% | 628 | $2K | |
| 99201 | <1% | 14 | $2K | |
| 85610 | <1% | 386 | $2K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 36 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 10,163 | $2K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 20 | $2K |
| 73030 | <1% | 57 | $1K | |
| 73562 | <1% | 80 | $1K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,394 | $1K |
| 84145 | <1% | 109 | $1K | |
| 80306 | <1% | 73 | $911.14 | |
| 97035 | <1% | 83 | $779.93 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 16 | $760.25 |
| 87040 | <1% | 164 | $690.88 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 12 | $665.01 |
| 87186 | <1% | 137 | $606.21 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 13 | $605.84 |
| 99000 | <1% | 110 | $558.99 | |
| 73130 | <1% | 30 | $517.30 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,482 | $487.76 |
| 85379 | <1% | 66 | $363.45 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 13 | $316.10 |
| 94761 | <1% | 2,809 | $286.33 | |
| 82805 | <1% | 13 | $279.37 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 43 | $273.97 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,018 | $230.92 |
| 86140 | <1% | 64 | $217.76 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 242 | $187.67 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,210 | $176.64 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 867 | $155.42 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,908 | $153.03 |
| 87088 | <1% | 43 | $146.95 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,986 | $136.58 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,394 | $126.24 |
| 80050 | General health panel | <1% | 12 | $39.10 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,394 | $38.98 |
| 85652 | <1% | 18 | $38.47 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,818 | $33.23 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 814 | $19.15 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 381 | $14.76 |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 154 | $12.83 |
| 96376 | <1% | 212 | $8.02 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 123 | $5.99 |
| 36000 | <1% | 31 | $5.10 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 605 | $3.01 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 14 | $2.93 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 24 | $2.16 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 648 | $1.26 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 62 | $0.62 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 14 | $0.24 |
| J3490 | Unclassified drugs | <1% | 243 | $0.13 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 30 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 29 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 36 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 57 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHNEDLER, LISA (CEO/PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Upland Hills Health, INC. | Mineral Point, WI | $42K |
| Upland Hills Health, INC. | Dodgeville, WI | $42K |
| Upland Hills Health, INC. | Mineral Point, WI | $41K |
| Upland Hills Health, INC, | Spring Green, WI | $32K |
| Upland Hills Health, INC. | Dodgeville, WI | $30K |
| Upland Hills Health, INC. | Montfort, WI | $28K |
| Upland Hills Health, INC | Mount Horeb, WI | $27K |
| Van Buren County Hospital | Keosauqua, IA | $17K |
| Upland Hills Health, INC | Barneveld, WI | $12K |
| Upland Hills Health INC | Dodgeville, WI | $4K |
| Upland Hills Health, INC. | Highland, WI | $3K |
| Upland Hills Health, INC | Barneveld, WI | $722.81 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.